Cargando…

Influence of Vincristine, Clinically Used in Cancer Therapy and Immune Thrombocytopenia, on the Function of Human Platelets

Vincristine is a clinically used antimicrotubule drug for treating patients with lymphoma. Due to its property of increasing platelet counts, vincristine is also used to treat patients with immune thrombocytopenia. Moreover, antiplatelet agents were reported to be beneficial in thrombotic thrombocyt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lien, Li-Ming, Lu, Wan-Jung, Lin, Kuan-Hung, Kang, Ling-Hsuan, Chen, Ting-Yu, Lin, Bo-Jung, Lu, Yung-Chang, Huang, Chun-Yao, Shih, Chun-Ming, Chen, Hsuan, Tsai, Yao-Chou, Chen, Ray-Jade, Sheu, Joen-Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434001/ https://www.ncbi.nlm.nih.gov/pubmed/34500771 http://dx.doi.org/10.3390/molecules26175340

Ejemplares similares

An Antithrombotic Strategy by Targeting Phospholipase D in Human Platelets
por: Lu, Wan Jung, et al.
Publicado: (2018)

Xanthohumol, a Prenylated Flavonoid from Hops (Humulus lupulus), Prevents Platelet Activation in Human Platelets
por: Lee, Ye-Ming, et al.
Publicado: (2012)

Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen–integrin α(II) (b)β(3) binding in human platelets
por: Hsia, Chih‐Hsuan, et al.
Publicado: (2018)

Effect of Antrodia camphorata on Inflammatory Arterial Thrombosis-Mediated Platelet Activation: The Pivotal Role of Protein Kinase C
por: Lu, Wan-Jung, et al.
Publicado: (2014)

A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies
por: Hsia, Chih-Hsuan, et al.
Publicado: (2017)

Amarogentin, a Secoiridoid Glycoside, Abrogates Platelet Activation through PLCγ2-PKC and MAPK Pathways
por: Yen, Ting-Lin, et al.
Publicado: (2014)

Author Correction: A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies
por: Hsia, Chih-Hsuan, et al.
Publicado: (2020)

New therapeutic strategy of hinokitiol in haemorrhagic shock‐induced liver injury
por: Lu, Wan‐Jung, et al.
Publicado: (2018)

Brazilin isolated from Caesalpinia sappan L. acts as a novel collagen receptor agonist in human platelets
por: Chang, Yi, et al.
Publicado: (2013)

Licochalcone A Prevents Platelet Activation and Thrombus Formation through the Inhibition of PLCγ2-PKC, Akt, and MAPK Pathways
por: Lien, Li-Ming, et al.
Publicado: (2017)

The Impact of Human Platelet Antigen Allele on Antiplatelet Antibodies and Cryoglobulins in Patients with Primary Immune Thrombocytopenia and Hepatitis C Virus-Associated Immune Thrombocytopenia
por: Huang, Cih-En, et al.
Publicado: (2023)

Suppression of Human Platelet Activation via Integrin α(IIb)β(3) Outside-In Independent Signal and Reduction of the Mortality in Pulmonary Thrombosis by Auraptene
por: Hsia, Chih-Wei, et al.
Publicado: (2019)

Synthetic Ruthenium Complex TQ-6 Potently Recovers Cerebral Ischemic Stroke: Attenuation of Microglia and Platelet Activation
por: Hsia, Chih-Hsuan, et al.
Publicado: (2020)

Application of vincristine-loaded platelet therapy in three dogs with refractory immune-mediated thrombocytopenia
por: Park, Hyung-Jin, et al.
Publicado: (2015)

Novel Bioactivity of Ellagic Acid in Inhibiting Human Platelet Activation
por: Chang, Yi, et al.
Publicado: (2013)

Nanodiamond-Induced Thrombocytopenia in Mice Involve P-Selectin-Dependent Nlrp3 Inflammasome-Mediated Platelet Aggregation, Pyroptosis and Apoptosis
por: Hung, Shih-Che, et al.
Publicado: (2022)

Novel Therapeutic Agent against Platelet Activation In Vitro and Arterial Thrombosis In Vivo by Morin Hydrate
por: Hsia, Chih-Wei, et al.
Publicado: (2018)

Mycobacterium tuberculosis Upregulates TNF-α Expression via TLR2/ERK Signaling and Induces MMP-1 and MMP-9 Production in Human Pleural Mesothelial Cells
por: Chen, Wei-Lin, et al.
Publicado: (2015)

A novel naphthalimide derivative reduces platelet activation and thrombus formation via suppressing GPVI
por: Shih, Tzenge‐Lien, et al.
Publicado: (2021)

Andrographolide induces vascular smooth muscle cell apoptosis through a SHP-1-PP2A-p38MAPK-p53 cascade
por: Chen, Yu-Ying, et al.
Publicado: (2014)

Honokiol as a specific collagen receptor glycoprotein VI antagonist on human platelets: Functional ex vivo and in vivo studies
por: Lee, Tzu-Yin, et al.
Publicado: (2017)

Embelin as a Novel Inhibitor of PKC in the Prevention of Platelet Activation and Thrombus Formation
por: Li, Jiun Yi, et al.
Publicado: (2019)

Glabridin, a Bioactive Flavonoid from Licorice, Effectively Inhibits Platelet Activation in Humans and Mice
por: Chung, Chi-Li, et al.
Publicado: (2022)

Hinokitiol Negatively Regulates Immune Responses through Cell Cycle Arrest in Concanavalin A-Activated Lymphocytes
por: Chung, Chi-Li, et al.
Publicado: (2015)

Regulation of Human Platelet Activation and Prevention of Arterial Thrombosis in Mice by Auraptene through Inhibition of NF-κB Pathway
por: Hsia, Chih-Wei, et al.
Publicado: (2020)

Comparison of free radical formation induced by baicalein and pentamethyl-hydroxychromane in human promyelocytic leukemia cells using electron spin resonance
por: Huang, Yung-Kai, et al.
Publicado: (2014)

Modulation of human platelet activation and in vivo vascular thrombosis by columbianadin: regulation by integrin α(IIb)β(3) inside-out but not outside-in signals
por: Hou, Shaw-Min, et al.
Publicado: (2020)

VAS2870 and VAS3947 attenuate platelet activation and thrombus formation via a NOX-independent pathway downstream of PKC
por: Lu, Wan Jung, et al.
Publicado: (2019)

Evaluation of pharyngeal airway volume for different dentofacial skeletal patterns using cone-beam computed tomography
por: Tseng, Yu-Chuan, et al.
Publicado: (2021)

Novel synthetic benzimidazole-derived oligosaccharide, M3BIM, prevents ex vivo platelet aggregation and in vivo thromboembolism
por: Yen, Ting-Lin, et al.
Publicado: (2016)

A novel role of sesamol in inhibiting NF-κB-mediated signaling in platelet activation
por: Chang, Chao-Chien, et al.
Publicado: (2011)

Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities
por: Tien, Feng-Ming, et al.
Publicado: (2023)

Evaluation of sexual dysfunction in gynecologic cancer survivors using DSM-5 diagnostic criteria
por: Lin, Hao, et al.
Publicado: (2022)

Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage
por: Chao, Chiao-Hsuan, et al.
Publicado: (2019)

Factors linked to severe thrombocytopenia during antiviral therapy in patients with chronic hepatitis c and pretreatment low platelet counts
por: Lin, Kung-Hung, et al.
Publicado: (2012)

Astaxanthin, a Carotenoid, Stimulates Immune Responses by Enhancing IFN-γ and IL-2 Secretion in Primary Cultured Lymphocytes in Vitro and ex Vivo
por: Lin, Kuan-Hung, et al.
Publicado: (2015)

Condylar and ramus volume in asymmetric and symmetric skeletal class III malocclusion: A cone-beam computed tomography study
por: Chou, Szu-Ting, et al.
Publicado: (2023)

Myricetin as a promising inhibitor of platelet fibrinogen receptor in humans
por: Chang, Yi, et al.
Publicado: (2023)

Phospholipase D1 and D2 Synergistically Regulate Thrombus Formation
por: Lien, Li-Ming, et al.
Publicado: (2020)

Neutropenia in dogs receiving vincristine for treatment of presumptive immune‐mediated thrombocytopenia
por: LaQuaglia, Kathryn A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j3akg2mk9rkgvjdpht7tfqb3k5